The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
Frilling
Andrea
A
Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany. a.frilling@imperial.ac.uk
Sotiropoulos
Georgios C
GC
Radtke
Arnold
A
Malago
Massimo
M
Bockisch
Andreas
A
Kuehl
Hilmar
H
Li
Jun
J
Broelsch
Christoph E
CE
D000328:Adult; D000368:Aged; D018450:Disease Progression; D005260:Female; D005710:Gallium Radioisotopes; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000473:pathology; D015282:Octreotide / Q000031:analogs & derivatives*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000379:methods*; D051598:Whole Body Imaging
D005710:Gallium Radioisotopes; D019275:Radiopharmaceuticals; D015282:Octreotide; C106246:Edotreotide